// App-Quantinova.ai

928 : Use of Disease Modifying Anti-rheumatic Drugs and Risk of Multiple Myeloma in US Veterans with Rheumatoid Arthritis

Researchers

Presenter

  • Namrata Singh

Principal Investigators

  • Alexander Peterson

  • Aaron Baraff

  • Sarah Chung

  • David Coffey

  • Bryant England

  • Pankti Reid

  • Joshua Baker

  • Jennifer Barton

  • Nicholas Smith

  • Ted Mikuls

  • Noel Weiss

Medical Centers

  • University of Washington, Seattle, WA

  • VA Puget Sound, SEATTLE, WA

  • University of Washington, Seattle, WA

  • University of Miami, Miami, FL

  • University of Nebraska Medical Center, Omaha, NE

  • The University of Chicago Medical Center, Chicago, IL

  • University of Pennsylvania, Philadelphia, PA

  • VA Portland Health Care System, Portland, OR

  • VA-Puget Sound/University of Washington, Seattle, WA

  • Division of Radiology, University of Nebraska Medical Center, Omaha, NE

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Rheumatoid arthritis

  • Multiple Myeloma

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Tocilizumab

  • leflunomide

  • Tasocitinib

  • Abatacept

  • Rituximab

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved